Literature DB >> 32785656

Low-grade Cortisol Cosecretion Has Limited Impact on ACTH-stimulated AVS Parameters in Primary Aldosteronism.

Samuel Matthew O'Toole1,2, Wing-Chiu Candy Sze1, Teng-Teng Chung3, Scott Alexander Akker1,2, Maralyn Rose Druce1,2, Mona Waterhouse1, Sarah Pitkin4, Anne Dawnay4, Anju Sahdev5, Matthew Matson5, Laila Parvanta6, William Martyn Drake1,2.   

Abstract

CONTEXT: In primary aldosteronism, cosecretion of cortisol may alter cortisol-derived adrenal venous sampling indices.
OBJECTIVE: To identify whether cortisol cosecretion in primary aldosteronism alters adrenal venous sampling parameters and interpretation.
DESIGN: Retrospective case-control study.
SETTING: A tertiary referral center. PATIENTS: 144 adult patients with primary aldosteronism who had undergone both adrenocorticotropic hormone-stimulated adrenal venous sampling and dexamethasone suppression testing between 2004 and 2018. MAIN OUTCOME MEASURES: Adrenal venous sampling indices including adrenal vein aldosterone/cortisol ratios and the selectivity, lateralization, and contralateral suppression indices.
RESULTS: 21 (14.6%) patients had evidence of cortisol cosecretion (defined as a failure to suppress cortisol to ≤50 nmol/L post dexamethasone). Patients with evidence of cortisol cosecretion had a higher inferior vena cava cortisol concentration (P = .01) than those without. No difference was observed between the groups in terms of selectivity index, lateralization index, lateralization of aldosterone excess, or adrenal vein cannulation rate.
CONCLUSIONS: Cortisol cosecretion alters some parameters in adrenocorticotrophic hormone-stimulated adrenal venous sampling but does not result in alterations in patient management. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  primary aldosteronism; adrenal venous sampling; adrenalectomy; cortisol; cortisol co-secretion

Year:  2020        PMID: 32785656     DOI: 10.1210/clinem/dgaa519

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Primary aldosteronism - a multidimensional syndrome.

Authors:  Adina F Turcu; Jun Yang; Anand Vaidya
Journal:  Nat Rev Endocrinol       Date:  2022-08-31       Impact factor: 47.564

2.  Variability of Aldosterone Measurements During Adrenal Venous Sampling for Primary Aldosteronism.

Authors:  Nicholas Yozamp; Gregory L Hundemer; Marwan Moussa; Johnathan Underhill; Tali Fudim; Barry Sacks; Anand Vaidya
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 3.080

3.  Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism.

Authors:  Mitsuhide Naruse; Akiyo Tanabe; Koichi Yamamoto; Hiromi Rakugi; Mitsuhiro Kometani; Takashi Yoneda; Hiroki Kobayashi; Masanori Abe; Youichi Ohno; Nobuya Inagaki; Shoichiro Izawa; Masakatsu Sone
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-21

4.  Comparison of Bolus and Continuous Infusion of Adrenocorticotropic Hormone During Adrenal Vein Sampling.

Authors:  Jinbo Hu; Jiangqiong Chen; Qingfeng Cheng; Ying Jing; Jun Yang; Zhipeng Du; Ying Song; Linqiang Ma; Yi Yang; Ting Luo; Yue Wang; Qifu Li; Shumin Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-26       Impact factor: 5.555

5.  Validation of three novel clinical prediction tools for primary aldosteronism subtyping.

Authors:  Tomaž Kocjan; Gaj Vidmar; Peter Popović; Milenko Stanković
Journal:  Endocr Connect       Date:  2022-05-11       Impact factor: 3.221

6.  Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling.

Authors:  Adina F Turcu; Richard Auchus
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

7.  Cortisol Co-Secretion and Clinical Usefulness of ACTH Stimulation Test in Primary Aldosteronism: A Systematic Review and Biases in Epidemiological Studies.

Authors:  Kosuke Inoue; Takumi Kitamoto; Yuya Tsurutani; Jun Saito; Masao Omura; Tetsuo Nishikawa
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.